BCAT1 and metabolic dysfunction-associated steatotic liver disease: And investigators studying adverse outcomes in non-alcoholic fatty liver disease showed that high BCAT1 expression and hypomethylation predicted an increased incidence of adverse outcomes such as hepatocellular carcinoma (HCC) (71).